 Elizabeth Kozora
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 14 | 2022 | 219 | 3.490 |
Why?
| | Cognition Disorders | 15 | 2022 | 476 | 2.920 |
Why?
| | Neuropsychological Tests | 21 | 2022 | 927 | 1.530 |
Why?
| | Cognition | 11 | 2022 | 989 | 1.300 |
Why?
| | Depression | 6 | 2011 | 1134 | 0.810 |
Why?
| | Leukoencephalopathies | 2 | 2013 | 21 | 0.800 |
Why?
| | Antiphospholipid Syndrome | 4 | 2016 | 26 | 0.800 |
Why?
| | Coronary Artery Bypass | 5 | 2019 | 196 | 0.780 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 6 | 2021 | 916 | 0.630 |
Why?
| | Antibodies, Antiphospholipid | 3 | 2016 | 21 | 0.600 |
Why?
| | Emphysema | 3 | 2011 | 107 | 0.580 |
Why?
| | Pulmonary Emphysema | 2 | 2011 | 272 | 0.560 |
Why?
| | Coronary Artery Bypass, Off-Pump | 6 | 2017 | 15 | 0.520 |
Why?
| | Memory Disorders | 4 | 2017 | 155 | 0.510 |
Why?
| | Cognitive Dysfunction | 4 | 2021 | 284 | 0.490 |
Why?
| | Lupus Vasculitis, Central Nervous System | 3 | 2018 | 7 | 0.470 |
Why?
| | Pneumonectomy | 2 | 2011 | 125 | 0.420 |
Why?
| | Trail Making Test | 1 | 2011 | 4 | 0.390 |
Why?
| | Attention | 4 | 2019 | 393 | 0.330 |
Why?
| | Memory | 5 | 2010 | 211 | 0.310 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 180 | 0.310 |
Why?
| | Antibodies | 1 | 2010 | 371 | 0.300 |
Why?
| | Smoking | 3 | 2020 | 1383 | 0.290 |
Why?
| | Executive Function | 4 | 2022 | 380 | 0.290 |
Why?
| | Middle Aged | 21 | 2020 | 26737 | 0.260 |
Why?
| | Fatigue | 2 | 2011 | 294 | 0.260 |
Why?
| | Nervous System Diseases | 1 | 2008 | 256 | 0.250 |
Why?
| | Quality of Life | 4 | 2021 | 2353 | 0.250 |
Why?
| | Anxiety | 2 | 2011 | 840 | 0.240 |
Why?
| | Humans | 38 | 2022 | 114689 | 0.240 |
Why?
| | Female | 24 | 2020 | 59511 | 0.200 |
Why?
| | Male | 24 | 2020 | 55599 | 0.200 |
Why?
| | Carotid Arteries | 2 | 2021 | 180 | 0.200 |
Why?
| | Behavior | 1 | 2002 | 92 | 0.200 |
Why?
| | Memory, Short-Term | 2 | 2013 | 225 | 0.180 |
Why?
| | Brain | 5 | 2018 | 2371 | 0.180 |
Why?
| | Psychometrics | 2 | 2017 | 608 | 0.180 |
Why?
| | Pain | 1 | 2006 | 705 | 0.180 |
Why?
| | Graft Occlusion, Vascular | 2 | 2019 | 35 | 0.180 |
Why?
| | Choline | 3 | 2013 | 106 | 0.180 |
Why?
| | Verbal Behavior | 2 | 2013 | 43 | 0.170 |
Why?
| | Carotid Artery Diseases | 1 | 2020 | 57 | 0.170 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2013 | 473 | 0.160 |
Why?
| | Treatment Outcome | 9 | 2019 | 9088 | 0.160 |
Why?
| | Angina Pectoris | 1 | 2019 | 63 | 0.160 |
Why?
| | Smokers | 1 | 2019 | 129 | 0.160 |
Why?
| | Frontal Lobe | 2 | 2013 | 141 | 0.160 |
Why?
| | Magnetic Resonance Imaging | 5 | 2018 | 3053 | 0.160 |
Why?
| | Psychomotor Performance | 3 | 2011 | 280 | 0.150 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2021 | 196 | 0.150 |
Why?
| | Adult | 11 | 2013 | 30550 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 250 | 0.140 |
Why?
| | Coronary Angiography | 1 | 2019 | 304 | 0.140 |
Why?
| | Learning | 2 | 2013 | 350 | 0.130 |
Why?
| | Autoantibodies | 3 | 2018 | 1346 | 0.130 |
Why?
| | Single-Blind Method | 3 | 2011 | 258 | 0.130 |
Why?
| | Physical Endurance | 2 | 2010 | 232 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2012 | 3003 | 0.130 |
Why?
| | Vascular Stiffness | 1 | 2020 | 407 | 0.120 |
Why?
| | Central Nervous System Diseases | 1 | 2016 | 61 | 0.120 |
Why?
| | Coronary Artery Disease | 2 | 2014 | 607 | 0.120 |
Why?
| | Aged | 10 | 2020 | 19074 | 0.120 |
Why?
| | Rheumatology | 2 | 2006 | 88 | 0.110 |
Why?
| | Coronary Circulation | 1 | 2014 | 133 | 0.110 |
Why?
| | Motor Skills | 1 | 2013 | 82 | 0.100 |
Why?
| | Health Status Indicators | 2 | 2011 | 156 | 0.100 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 82 | 0.100 |
Why?
| | Prospective Studies | 3 | 2019 | 6220 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2017 | 4411 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2014 | 2128 | 0.100 |
Why?
| | Creatinine | 1 | 2013 | 425 | 0.100 |
Why?
| | Neurologic Examination | 2 | 2008 | 114 | 0.090 |
Why?
| | Linear Models | 2 | 2011 | 768 | 0.090 |
Why?
| | Immunologic Factors | 1 | 2013 | 220 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2540 | 0.090 |
Why?
| | Regression Analysis | 1 | 2013 | 945 | 0.090 |
Why?
| | Forced Expiratory Volume | 1 | 2011 | 475 | 0.090 |
Why?
| | Cardiopulmonary Bypass | 1 | 2011 | 178 | 0.090 |
Why?
| | Acetylcholine | 1 | 2010 | 166 | 0.080 |
Why?
| | Aspartic Acid | 2 | 2009 | 77 | 0.080 |
Why?
| | Brain Chemistry | 2 | 2009 | 115 | 0.080 |
Why?
| | Neuroimaging | 1 | 2011 | 249 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2006 | 2765 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 323 | 0.070 |
Why?
| | Muscle Strength | 1 | 2010 | 271 | 0.070 |
Why?
| | West Nile Fever | 1 | 2008 | 50 | 0.070 |
Why?
| | Coronary Disease | 1 | 2009 | 348 | 0.070 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2008 | 129 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 547 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1013 | 0.070 |
Why?
| | Multiple Sclerosis | 2 | 2016 | 376 | 0.070 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 900 | 0.070 |
Why?
| | Prednisone | 1 | 2006 | 229 | 0.060 |
Why?
| | Mental Processes | 1 | 2005 | 34 | 0.060 |
Why?
| | Ohio | 1 | 2005 | 135 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2387 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 743 | 0.060 |
Why?
| | Lung | 2 | 2019 | 3561 | 0.060 |
Why?
| | Respiratory Function Tests | 2 | 2019 | 522 | 0.060 |
Why?
| | Pain Measurement | 1 | 2006 | 444 | 0.060 |
Why?
| | Biomarkers | 1 | 2013 | 3408 | 0.050 |
Why?
| | Language | 1 | 2005 | 263 | 0.050 |
Why?
| | Vascular Patency | 2 | 2014 | 97 | 0.050 |
Why?
| | United States Department of Veterans Affairs | 2 | 2019 | 561 | 0.050 |
Why?
| | United States | 4 | 2019 | 12183 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 811 | 0.050 |
Why?
| | Risk Factors | 3 | 2020 | 8632 | 0.050 |
Why?
| | Carotid Artery, Common | 1 | 2021 | 29 | 0.050 |
Why?
| | Hippocampus | 1 | 2005 | 693 | 0.050 |
Why?
| | Reaction Time | 2 | 2017 | 376 | 0.050 |
Why?
| | Societies, Medical | 1 | 2004 | 664 | 0.050 |
Why?
| | Risk Assessment | 2 | 2020 | 2968 | 0.040 |
Why?
| | Time Factors | 3 | 2019 | 6116 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 1644 | 0.040 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 4623 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2021 | 349 | 0.040 |
Why?
| | Blood-Brain Barrier | 1 | 2018 | 106 | 0.040 |
Why?
| | Pilot Projects | 2 | 2013 | 1373 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 259 | 0.040 |
Why?
| | Self-Assessment | 1 | 2017 | 60 | 0.040 |
Why?
| | Culture | 1 | 2017 | 124 | 0.030 |
Why?
| | Colorado | 1 | 2005 | 4099 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 620 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1430 | 0.030 |
Why?
| | Movement Disorders | 1 | 2016 | 48 | 0.030 |
Why?
| | Brain Ischemia | 1 | 2018 | 299 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 10470 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1796 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1214 | 0.030 |
Why?
| | Age Factors | 1 | 2019 | 2894 | 0.030 |
Why?
| | Coronary Vessels | 1 | 2014 | 227 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 17848 | 0.020 |
Why?
| | Rituximab | 1 | 2013 | 150 | 0.020 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 76 | 0.020 |
Why?
| | Spiritualism | 1 | 2011 | 1 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4410 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 1841 | 0.020 |
Why?
| | Religion | 1 | 2011 | 64 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 424 | 0.020 |
Why?
| | Creatine | 1 | 2009 | 50 | 0.020 |
Why?
| | Health Resources | 1 | 2009 | 122 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2480 | 0.020 |
Why?
| | Mental Disorders | 1 | 2016 | 892 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 33 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2313 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2011 | 233 | 0.020 |
Why?
| | Axons | 1 | 2009 | 177 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 599 | 0.020 |
Why?
| | Walking | 1 | 2011 | 422 | 0.020 |
Why?
| | Technology Assessment, Biomedical | 1 | 2007 | 29 | 0.020 |
Why?
| | Sample Size | 1 | 2007 | 112 | 0.020 |
Why?
| | Veterans | 1 | 2017 | 1249 | 0.020 |
Why?
| | Prevalence | 1 | 2012 | 2251 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1727 | 0.020 |
Why?
| | Verbal Learning | 1 | 2005 | 63 | 0.020 |
Why?
| | Health Surveys | 1 | 2007 | 443 | 0.020 |
Why?
| | Safety | 1 | 2007 | 297 | 0.010 |
Why?
| | Research Design | 1 | 2007 | 928 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 12551 | 0.010 |
Why?
|
|
Kozora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|